On the Dichotomous Aspect of Cancer Stem Cell
Journal: Open Access Journal of Cancer & Oncology (Vol.2, No. 2)Publication Date: 2018-03-02
Authors : Hugwil AV;
Page : 1-4
Keywords : Dichotomous; Stem Cell; Soncogenic; Vimentin; 14-3-3; EMT/MET; Prions; Pritumumab;
Abstract
Hundred of oncogenes and suppressor oncogenes (soncogenes) have been identified. However cancer is still a formidable conundrum for cancer cell biologists and oncologists. During the last 30 years I have been developing a human monoclonal antibody CLN-IgG (INN: Pritumumab) as a new pharmaceutical agent against brain tumors. Its efficacy includes complete remission (CR) and partial remission (PR) at over 28%.
Other Latest Articles
- Novel Docetaxel Formulation (NDLS) in Low Cardiac Reserve Ovarian Cancer
- Upper Eyelid Fistula Secondary to a Frontal Sinusitis: A Case Report and Review of the Literature
- As Long as I Work I will Live
- Inflammation and Breast Cancer
- Evaluation of Bond Strength & Enamel Alterations with the Contemporary Light Cure Orthodontic Adhesives: A Scanning Electron Microscope Study
Last modified: 2019-03-30 19:47:53